FOXTROT™ PRO Gains Market Approval in Indonesia

Shanghai, China – FOXTROT™ PRO PTCA Balloon Dilatation Catheter ("FOXTROT™ PRO"), a product in-house developed by Shanghai MicroPort Medical (Group) Co ("MicroPort®"), recently received approval for market launch in Indonesia.
FOXTROT™ PRO is a rapid exchange balloon catheter for percutaneous transluminal coronary angioplasty ("PTCA"). Made of advanced balloon material, FOXTROT™ PRO has superior crossability and trackability. It features smooth tip with the unique "soft-tip." The distal tip is seamlessly bonded by advanced laser welding technique. Its super-long hydrophilic coating largely enhances its pushability and crossability, and its best-in-class shaft profile offers full capability of kissing balloon through 6F guiding catheter.
As MicroPort®'s second generation of PTCA balloon catheter after JIVE™ PTCA Balloon Catheter, FOXTROT™ PRO has gained market approval in Thailand, Argentina and Brazil. As it is permitted to launch in Indonesia, MicroPort® will further expand our overseas market and diversify our cardiovascular product line.